Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women

Journal of Infectious Diseases

Volumn 176, Issue 4, 1997, Pages 876-883

  Svare, Edith I ^a   Kjaer, Susanne Krüger ^d   Nonnenmacher, Bernadete ^b   Worm, Anne Marie ^d   Moi, Harald ^c   Christensen, René B ^d   Van Den Brule, Adriaan J C ^d   Walboomers, Jan M M ^d   Meijer, Chris J L M ^d   Hubbert, Nancy L ^d   Lowy, Douglas R ^d   Schiller, John T ^d  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER;

ADOLESCENT; ADULT; ARTICLE; DNA DETERMINATION; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; VIRUS INFECTION; VIRUS PARTICLE; WART VIRUS;

EID: 16944364595     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516505     Document Type: Article

References (27)

1. Zunzunegui MV, King MC, Coria CF, Charlet J. Male influences on cervical cancer risk. Am J Epidemiol 1986;123:302-7.
2. Brinton LA, Reeves WC, Brenes MM, et al. The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer 1989;44:199-203.
3. Kjaer SK, de Villiers EM, Dahl C, et al. Case-control study of risk factors for cervical neoplasia in Denmark. I: Role of the "male factor" in women with one lifetime sexual partner. Int J Cancer 1991;48:39-44.
4. Bosch FX, Castellsague X, Muñoz N, et al. Male sexual behaviour and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996;88:1060-7.
5. Muñoz N, Castellsague X, Bosch FX, et al. Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. J Natl Cancer Inst 1996;88:1068-75.
6. World Health Organization. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 1995;64.
7. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
8. Kjaer SK, van den Brule AJC, Bock JE, et al. Human papillomavirus - the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996;65:601-6.
9. Wheeler CM, Parmenter CA, Hunt WC, et al. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis 1993;20:286-9.
10. Bauer HM, Hildesheim A, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993;20:274-8.
11. Hinchliffe SA, van Velzen D, Korporaal H, Kok PL, Boon ME. Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology. Br J Cancer 1995;72:943-5.
12. Schiffman MH. Recent progress in defining the epidemiology of human papillomavirus and cervical neoplasia. J Natl Cancer Inst 1992;84:394-7.
13. Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT. Papillomavirus LI major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci USA 1992;89:12180-4.
14. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994;86:494-9.
15. Nonnenmacher B, Hubbert NL, Kirnbauer R, et al. Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J Infect Dis 1995;172:19-24.
16. Dillner J, Wiklund F, Lenner P, et al. Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer. Int J Cancer 1995;60:377-82.
17. Nonnenmacher B, Kjaer SK, Svare EI, et al. Seroreactivity to HPV-16 virus-like particles as a marker for cervical cancer risk in high-risk populations. Int J Cancer 1996;68:704-9.
18. Wideroff L, Schiffman MH, Nonnenmacher B, et al. Evaluation of serore-activity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis 1995;172:1425-30.
19. van den Brule AJC, Snijders PJ, Gordijn RL, Bleker OP, Meijer CJ, Walboomers JM. General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int J Cancer 1990;45:644-9.
20. van den Brule AJC, Meijer CJLM, Bakels V, Kenemans P, Walboomers JMM. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol 1990;28:2739-43.
21. de Roda Husman AM, Walboomers JMM, Meijer CJLM, et al. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer 1994;56:802-6.
22. SAS/STAT user's guide. 4th ed. Vol 1, 2. Cary, NC: SAS Institute, 1989.
23. Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 1995;33:2058-63.
24. Carter JJ, Wipf GC, Hagensee ME, et al. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. J Infect Dis 1995;172:11-8.
25. Hira S, Kamanga J, Macuacua R, Mwansa N, Cruess D, Perine P. Genital ulcers and male circumcision as risk factors for acquiring human immunodeficiency virus type 1 in Zambia. J Infect Dis 1990;161:584-5.
26. Olsen AO, Dillner J, Gjoen K, Sauer T, Ørstavik I, Magnus P. A population-based study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix. Int J Cancer 1996;68:415-9.
27. Wideroff L, Schiffman MH, Hoover R, et al. Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and -negative women. J Infect Dis 1996;174:937-43.